scholarly journals Fas Ligand Expression in Metastatic Renal Cell Carcinoma During Interleukin-2 Based Immunotherapy

2004 ◽  
Vol 10 (23) ◽  
pp. 7911-7916 ◽  
Author(s):  
Frede Donskov ◽  
Hans von der Maase ◽  
Niels Marcussen ◽  
Stephen Hamilton-Dutoit ◽  
Hans Henrik Torp Madsen ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Fas Ligand ◽  
Interleukin 2 ◽  
Ligand Expression

scholarly journals A Phase I Study of High-Dose Interleukin-2 With Sorafenib in Patients With Metastatic Renal Cell Carcinoma and Melanoma

2014 ◽  
Vol 37 (3) ◽  
pp. 180-186 ◽  
Author(s):  
Paul Monk ◽  
Elaine Lam ◽  
Amir Mortazavi ◽  
Kari Kendra ◽  
Gregory B. Lesinski ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase I Study ◽  
Interleukin 2 ◽  
High Dose

scholarly journals Conditional survival of metastatic renal cell carcinoma patients treated with high-dose interleukin-2

2016 ◽  
Vol 10 ◽  
Author(s):  
David M Gill ◽  
David D Stenehjem ◽  
Kinjal Parikh ◽  
Joseph Merriman ◽  
Arun Sendilnathan ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Interleukin 2 ◽  
High Dose ◽  
Conditional Survival

Prognostic markers for survival in patients with metastatic renal cell carcinoma treated with interleukin-2

1997 ◽  
Vol 43 (5) ◽  
pp. 293-298 ◽  
Author(s):  
Rutger L. van Bezooijen ◽  
H. Goey ◽  
Gerrit Stoter ◽  
J. Hermans ◽  
G. J. Fleuren
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Prognostic Markers ◽  
Interleukin 2
Sign in / Sign up

Export Citation Format

Share Document